Selected research
Industry Research
Pre-marital and Pre-Pregnancy Genetic Testing Service Industry Research Report 2026
Market perspective
The global Pre-marital and Pre-Pregnancy Genetic Testing Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Pre-marital and Pre-Pregnancy Genetic Testing Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Pre-marital and Pre-Pregnancy Genetic Testing Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Pre-marital and Pre-Pregnancy Genetic Testing Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Pre-marital and Pre-Pregnancy Genetic Testing Service include Illumina, Fulgent Genetics, Natera, NxGen MDx, LLC, Sonic Genetics, MedGenome Labs, My Baby Company, Clinical Labs and Eurofins Scientific, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Pre-marital and Pre-Pregnancy Genetic Testing Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Pre-marital and Pre-Pregnancy Genetic Testing Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pre-marital and Pre-Pregnancy Genetic Testing Service Market by Company
Illumina
Fulgent Genetics
Natera
NxGen MDx, LLC
Sonic Genetics
MedGenome Labs
My Baby Company
Clinical Labs
Eurofins Scientific
OPKO Health
Gene by Gene
Invitae
Myriad Genetics
Thermo Fisher Scientific
BGI
Berry Genomics
Kingmed Diagnostic
Dian Diagnostics Group
Adicon
Zhongyuan Concord
WuXi AppTec
Novogene
AmoyDx
Centogene
Genoma Group
SRL Inc.
LSI Medience
GC Genome
Seegene
Huizhi Gene
Pre-marital and Pre-Pregnancy Genetic Testing Service Segment by Type
Premarital Genetic Testing
Preconception Genetic Testing
Pre-marital and Pre-Pregnancy Genetic Testing Service Segment by Application
Premarital Population
Couples Planning for Pregnancy
People with a Family History of Genetic Diseases
People Undergoing Assisted Reproductive Technology (IVF)
Pre-marital and Pre-Pregnancy Genetic Testing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pre-marital and Pre-Pregnancy Genetic Testing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pre-marital and Pre-Pregnancy Genetic Testing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pre-marital and Pre-Pregnancy Genetic Testing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Pre-marital and Pre-Pregnancy Genetic Testing Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Premarital Genetic Testing
- Preconception Genetic Testing
Applications
- Premarital Population
- Couples Planning for Pregnancy
- People with a Family History of Genetic Diseases
- People Undergoing Assisted Reproductive Technology (IVF)
Companies covered
- Illumina
- Fulgent Genetics
- Natera
- NxGen MDx, LLC
- Sonic Genetics
- MedGenome Labs
- My Baby Company
- Clinical Labs
- Eurofins Scientific
- OPKO Health
- Gene by Gene
- Invitae
- Myriad Genetics
- Thermo Fisher Scientific
- BGI
- Berry Genomics
- Kingmed Diagnostic
- Dian Diagnostics Group
- Adicon
- Zhongyuan Concord
- WuXi AppTec
- Novogene
- AmoyDx
- Centogene
- Genoma Group
- SRL Inc.
- LSI Medience
- GC Genome
- Seegene
- Huizhi Gene
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Pre-marital and Pre-Pregnancy Genetic Testing Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Premarital Genetic Testing
- 2.2.3 Preconception Genetic Testing
- 2.3 Pre-marital and Pre-Pregnancy Genetic Testing Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Premarital Population
- 2.3.3 Couples Planning for Pregnancy
- 2.3.4 People with a Family History of Genetic Diseases
- 2.3.5 People Undergoing Assisted Reproductive Technology (IVF)
- 2.4 Assumptions and Limitations
3 Pre-marital and Pre-Pregnancy Genetic Testing Service Breakdown Data by Type
- 3.1 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Historic Market Size by Type (2021-2026)
- 3.2 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Forecasted Market Size by Type (2027-2032)
4 Pre-marital and Pre-Pregnancy Genetic Testing Service Breakdown Data by Application
- 4.1 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Historic Market Size by Application (2021-2026)
- 4.2 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Market Perspective (2021-2032)
- 5.2 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Growth Trends by Region
- 5.2.1 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Pre-marital and Pre-Pregnancy Genetic Testing Service Historic Market Size by Region (2021-2026)
- 5.2.3 Pre-marital and Pre-Pregnancy Genetic Testing Service Forecasted Market Size by Region (2027-2032)
- 5.3 Pre-marital and Pre-Pregnancy Genetic Testing Service Market Dynamics
- 5.3.1 Pre-marital and Pre-Pregnancy Genetic Testing Service Industry Trends
- 5.3.2 Pre-marital and Pre-Pregnancy Genetic Testing Service Market Drivers
- 5.3.3 Pre-marital and Pre-Pregnancy Genetic Testing Service Market Challenges
- 5.3.4 Pre-marital and Pre-Pregnancy Genetic Testing Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Pre-marital and Pre-Pregnancy Genetic Testing Service Players by Revenue
- 6.1.1 Global Top Pre-marital and Pre-Pregnancy Genetic Testing Service Players by Revenue (2021-2026)
- 6.1.2 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Pre-marital and Pre-Pregnancy Genetic Testing Service Head Office and Area Served
- 6.4 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Players, Product Type & Application
- 6.5 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Manufacturers Established Date
- 6.6 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Pre-marital and Pre-Pregnancy Genetic Testing Service Market Size (2021-2032)
- 7.2 North America Pre-marital and Pre-Pregnancy Genetic Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Pre-marital and Pre-Pregnancy Genetic Testing Service Market Size by Country (2021-2026)
- 7.4 North America Pre-marital and Pre-Pregnancy Genetic Testing Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Pre-marital and Pre-Pregnancy Genetic Testing Service Market Size (2021-2032)
- 8.2 Europe Pre-marital and Pre-Pregnancy Genetic Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Pre-marital and Pre-Pregnancy Genetic Testing Service Market Size by Country (2021-2026)
- 8.4 Europe Pre-marital and Pre-Pregnancy Genetic Testing Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Pre-marital and Pre-Pregnancy Genetic Testing Service Market Size (2021-2032)
- 9.2 Asia-Pacific Pre-marital and Pre-Pregnancy Genetic Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Pre-marital and Pre-Pregnancy Genetic Testing Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Pre-marital and Pre-Pregnancy Genetic Testing Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Pre-marital and Pre-Pregnancy Genetic Testing Service Market Size (2021-2032)
- 10.2 South America Pre-marital and Pre-Pregnancy Genetic Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Pre-marital and Pre-Pregnancy Genetic Testing Service Market Size by Country (2021-2026)
- 10.4 South America Pre-marital and Pre-Pregnancy Genetic Testing Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Pre-marital and Pre-Pregnancy Genetic Testing Service Market Size (2021-2032)
- 11.2 Middle East & Africa Pre-marital and Pre-Pregnancy Genetic Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Pre-marital and Pre-Pregnancy Genetic Testing Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Pre-marital and Pre-Pregnancy Genetic Testing Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Illumina
- 12.1.1 Illumina Company Information
- 12.1.2 Illumina Business Overview
- 12.1.3 Illumina Revenue in Pre-marital and Pre-Pregnancy Genetic Testing Service Business (2021-2026)
- 12.1.4 Illumina Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 12.1.5 Illumina Recent Developments
- 12.2 Fulgent Genetics
- 12.2.1 Fulgent Genetics Company Information
- 12.2.2 Fulgent Genetics Business Overview
- 12.2.3 Fulgent Genetics Revenue in Pre-marital and Pre-Pregnancy Genetic Testing Service Business (2021-2026)
- 12.2.4 Fulgent Genetics Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 12.2.5 Fulgent Genetics Recent Developments
- 12.3 Natera
- 12.3.1 Natera Company Information
- 12.3.2 Natera Business Overview
- 12.3.3 Natera Revenue in Pre-marital and Pre-Pregnancy Genetic Testing Service Business (2021-2026)
- 12.3.4 Natera Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 12.3.5 Natera Recent Developments
- 12.4 NxGen MDx, LLC
- 12.4.1 NxGen MDx, LLC Company Information
- 12.4.2 NxGen MDx, LLC Business Overview
- 12.4.3 NxGen MDx, LLC Revenue in Pre-marital and Pre-Pregnancy Genetic Testing Service Business (2021-2026)
- 12.4.4 NxGen MDx, LLC Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 12.4.5 NxGen MDx, LLC Recent Developments
- 12.5 Sonic Genetics
- 12.5.1 Sonic Genetics Company Information
- 12.5.2 Sonic Genetics Business Overview
- 12.5.3 Sonic Genetics Revenue in Pre-marital and Pre-Pregnancy Genetic Testing Service Business (2021-2026)
- 12.5.4 Sonic Genetics Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 12.5.5 Sonic Genetics Recent Developments
- 12.6 MedGenome Labs
- 12.6.1 MedGenome Labs Company Information
- 12.6.2 MedGenome Labs Business Overview
- 12.6.3 MedGenome Labs Revenue in Pre-marital and Pre-Pregnancy Genetic Testing Service Business (2021-2026)
- 12.6.4 MedGenome Labs Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 12.6.5 MedGenome Labs Recent Developments
- 12.7 My Baby Company
- 12.7.1 My Baby Company Company Information
- 12.7.2 My Baby Company Business Overview
- 12.7.3 My Baby Company Revenue in Pre-marital and Pre-Pregnancy Genetic Testing Service Business (2021-2026)
- 12.7.4 My Baby Company Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 12.7.5 My Baby Company Recent Developments
- 12.8 Clinical Labs
- 12.8.1 Clinical Labs Company Information
- 12.8.2 Clinical Labs Business Overview
- 12.8.3 Clinical Labs Revenue in Pre-marital and Pre-Pregnancy Genetic Testing Service Business (2021-2026)
- 12.8.4 Clinical Labs Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 12.8.5 Clinical Labs Recent Developments
- 12.9 Eurofins Scientific
- 12.9.1 Eurofins Scientific Company Information
- 12.9.2 Eurofins Scientific Business Overview
- 12.9.3 Eurofins Scientific Revenue in Pre-marital and Pre-Pregnancy Genetic Testing Service Business (2021-2026)
- 12.9.4 Eurofins Scientific Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 12.9.5 Eurofins Scientific Recent Developments
- 12.10 OPKO Health
- 12.10.1 OPKO Health Company Information
- 12.10.2 OPKO Health Business Overview
- 12.10.3 OPKO Health Revenue in Pre-marital and Pre-Pregnancy Genetic Testing Service Business (2021-2026)
- 12.10.4 OPKO Health Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 12.10.5 OPKO Health Recent Developments
- 12.11 Gene by Gene
- 12.11.1 Gene by Gene Company Information
- 12.11.2 Gene by Gene Business Overview
- 12.11.3 Gene by Gene Revenue in Pre-marital and Pre-Pregnancy Genetic Testing Service Business (2021-2026)
- 12.11.4 Gene by Gene Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 12.11.5 Gene by Gene Recent Developments
- 12.12 Invitae
- 12.12.1 Invitae Company Information
- 12.12.2 Invitae Business Overview
- 12.12.3 Invitae Revenue in Pre-marital and Pre-Pregnancy Genetic Testing Service Business (2021-2026)
- 12.12.4 Invitae Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 12.12.5 Invitae Recent Developments
- 12.13 Myriad Genetics
- 12.13.1 Myriad Genetics Company Information
- 12.13.2 Myriad Genetics Business Overview
- 12.13.3 Myriad Genetics Revenue in Pre-marital and Pre-Pregnancy Genetic Testing Service Business (2021-2026)
- 12.13.4 Myriad Genetics Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 12.13.5 Myriad Genetics Recent Developments
- 12.14 Thermo Fisher Scientific
- 12.14.1 Thermo Fisher Scientific Company Information
- 12.14.2 Thermo Fisher Scientific Business Overview
- 12.14.3 Thermo Fisher Scientific Revenue in Pre-marital and Pre-Pregnancy Genetic Testing Service Business (2021-2026)
- 12.14.4 Thermo Fisher Scientific Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 12.14.5 Thermo Fisher Scientific Recent Developments
- 12.15 BGI
- 12.15.1 BGI Company Information
- 12.15.2 BGI Business Overview
- 12.15.3 BGI Revenue in Pre-marital and Pre-Pregnancy Genetic Testing Service Business (2021-2026)
- 12.15.4 BGI Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 12.15.5 BGI Recent Developments
- 12.16 Berry Genomics
- 12.16.1 Berry Genomics Company Information
- 12.16.2 Berry Genomics Business Overview
- 12.16.3 Berry Genomics Revenue in Pre-marital and Pre-Pregnancy Genetic Testing Service Business (2021-2026)
- 12.16.4 Berry Genomics Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 12.16.5 Berry Genomics Recent Developments
- 12.17 Kingmed Diagnostic
- 12.17.1 Kingmed Diagnostic Company Information
- 12.17.2 Kingmed Diagnostic Business Overview
- 12.17.3 Kingmed Diagnostic Revenue in Pre-marital and Pre-Pregnancy Genetic Testing Service Business (2021-2026)
- 12.17.4 Kingmed Diagnostic Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 12.17.5 Kingmed Diagnostic Recent Developments
- 12.18 Dian Diagnostics Group
- 12.18.1 Dian Diagnostics Group Company Information
- 12.18.2 Dian Diagnostics Group Business Overview
- 12.18.3 Dian Diagnostics Group Revenue in Pre-marital and Pre-Pregnancy Genetic Testing Service Business (2021-2026)
- 12.18.4 Dian Diagnostics Group Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 12.18.5 Dian Diagnostics Group Recent Developments
- 12.19 Adicon
- 12.19.1 Adicon Company Information
- 12.19.2 Adicon Business Overview
- 12.19.3 Adicon Revenue in Pre-marital and Pre-Pregnancy Genetic Testing Service Business (2021-2026)
- 12.19.4 Adicon Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 12.19.5 Adicon Recent Developments
- 12.20 Zhongyuan Concord
- 12.20.1 Zhongyuan Concord Company Information
- 12.20.2 Zhongyuan Concord Business Overview
- 12.20.3 Zhongyuan Concord Revenue in Pre-marital and Pre-Pregnancy Genetic Testing Service Business (2021-2026)
- 12.20.4 Zhongyuan Concord Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 12.20.5 Zhongyuan Concord Recent Developments
- 12.21 WuXi AppTec
- 12.21.1 WuXi AppTec Company Information
- 12.21.2 WuXi AppTec Business Overview
- 12.21.3 WuXi AppTec Revenue in Pre-marital and Pre-Pregnancy Genetic Testing Service Business (2021-2026)
- 12.21.4 WuXi AppTec Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 12.21.5 WuXi AppTec Recent Developments
- 12.22 Novogene
- 12.22.1 Novogene Company Information
- 12.22.2 Novogene Business Overview
- 12.22.3 Novogene Revenue in Pre-marital and Pre-Pregnancy Genetic Testing Service Business (2021-2026)
- 12.22.4 Novogene Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 12.22.5 Novogene Recent Developments
- 12.23 AmoyDx
- 12.23.1 AmoyDx Company Information
- 12.23.2 AmoyDx Business Overview
- 12.23.3 AmoyDx Revenue in Pre-marital and Pre-Pregnancy Genetic Testing Service Business (2021-2026)
- 12.23.4 AmoyDx Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 12.23.5 AmoyDx Recent Developments
- 12.24 Centogene
- 12.24.1 Centogene Company Information
- 12.24.2 Centogene Business Overview
- 12.24.3 Centogene Revenue in Pre-marital and Pre-Pregnancy Genetic Testing Service Business (2021-2026)
- 12.24.4 Centogene Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 12.24.5 Centogene Recent Developments
- 12.25 Genoma Group
- 12.25.1 Genoma Group Company Information
- 12.25.2 Genoma Group Business Overview
- 12.25.3 Genoma Group Revenue in Pre-marital and Pre-Pregnancy Genetic Testing Service Business (2021-2026)
- 12.25.4 Genoma Group Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 12.25.5 Genoma Group Recent Developments
- 12.26 SRL Inc.
- 12.26.1 SRL Inc. Company Information
- 12.26.2 SRL Inc. Business Overview
- 12.26.3 SRL Inc. Revenue in Pre-marital and Pre-Pregnancy Genetic Testing Service Business (2021-2026)
- 12.26.4 SRL Inc. Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 12.26.5 SRL Inc. Recent Developments
- 12.27 LSI Medience
- 12.27.1 LSI Medience Company Information
- 12.27.2 LSI Medience Business Overview
- 12.27.3 LSI Medience Revenue in Pre-marital and Pre-Pregnancy Genetic Testing Service Business (2021-2026)
- 12.27.4 LSI Medience Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 12.27.5 LSI Medience Recent Developments
- 12.28 GC Genome
- 12.28.1 GC Genome Company Information
- 12.28.2 GC Genome Business Overview
- 12.28.3 GC Genome Revenue in Pre-marital and Pre-Pregnancy Genetic Testing Service Business (2021-2026)
- 12.28.4 GC Genome Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 12.28.5 GC Genome Recent Developments
- 12.29 Seegene
- 12.29.1 Seegene Company Information
- 12.29.2 Seegene Business Overview
- 12.29.3 Seegene Revenue in Pre-marital and Pre-Pregnancy Genetic Testing Service Business (2021-2026)
- 12.29.4 Seegene Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 12.29.5 Seegene Recent Developments
- 12.30 Huizhi Gene
- 12.30.1 Huizhi Gene Company Information
- 12.30.2 Huizhi Gene Business Overview
- 12.30.3 Huizhi Gene Revenue in Pre-marital and Pre-Pregnancy Genetic Testing Service Business (2021-2026)
- 12.30.4 Huizhi Gene Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 12.30.5 Huizhi Gene Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst